GRANULAR THERAPEUTICS LIMITED
Company number 10650696 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£7,933,543
Balance sheet as at 2023-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2017-03-03
- Employees
- 5 (2023 accounts · was 4 in 2022)
- Registered office
- C/O Kreston Reeves Llp Innovation House, Ramsgate Road, Sandwich, Kent, United Kingdom, CT13 9FF
- Postcode
- CT13 9FF
- Capital
- 115 GBP
- Accounts category
- Small
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-01-21
- Next due by
- 2027-02-04
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current · 5 resigned
Thibaud, Dr PORTAL
Director
JON EDWARDS
Director
Contact details
- Website
- granulartherapeutics.com
Granular Therapeutics is now a fully owned subsidiary of Alys Pharmaceuticals
Previous company names
| Name | Date changed |
|---|---|
| ULTRAHUMAN FIVE LIMITED | 2021-02-04 |
Previous registered addresses 1
| Address | Changed on |
|---|---|
| C/O MEDICXI 25 GREAT PULTENEY STREET, SOHO, LONDON, W1F 9LT, ENGLAND | 2017-08-30 |
At this address
Among the biggest employers
of 18 similar companies in CT, with 5 staff.
Competitors Canterbury
This company ranks 30 among research and experimental development on biotechnology in Canterbury.
The class of 2017
36%
of the 435 companies in this sector incorporated in 2017 are still active today; 61% have since been dissolved.
A fact about the year, not a forecast for this company.